139 related articles for article (PubMed ID: 19301921)
1. Structure revision of the lantibiotic 97518.
Maffioli SI; Potenza D; Vasile F; De Matteo M; Sosio M; Marsiglia B; Rizzo V; Scolastico C; Donadio S
J Nat Prod; 2009 Apr; 72(4):605-7. PubMed ID: 19301921
[TBL] [Abstract][Full Text] [Related]
2. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
4. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.
Castiglione F; Lazzarini A; Carrano L; Corti E; Ciciliato I; Gastaldo L; Candiani P; Losi D; Marinelli F; Selva E; Parenti F
Chem Biol; 2008 Jan; 15(1):22-31. PubMed ID: 18215770
[TBL] [Abstract][Full Text] [Related]
5. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
6. Solution structure by nuclear magnetic resonance of the two lantibiotics 97518 and NAI-107.
Vasile F; Potenza D; Marsiglia B; Maffioli S; Donadio S
J Pept Sci; 2012 Feb; 18(2):129-34. PubMed ID: 22083835
[TBL] [Abstract][Full Text] [Related]
7. A unique lantibiotic, thermophilin 1277, containing a disulfide bridge and two thioether bridges.
Kabuki T; Uenishi H; Seto Y; Yoshioka T; Nakajima H
J Appl Microbiol; 2009 Mar; 106(3):853-62. PubMed ID: 19191960
[TBL] [Abstract][Full Text] [Related]
8. Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.
Shenkarev ZO; Finkina EI; Nurmukhamedova EK; Balandin SV; Mineev KS; Nadezhdin KD; Yakimenko ZA; Tagaev AA; Temirov YV; Arseniev AS; Ovchinnikova TV
Biochemistry; 2010 Aug; 49(30):6462-72. PubMed ID: 20578714
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the congeners in the lantibiotic NAI-107 complex.
Maffioli SI; Iorio M; Sosio M; Monciardini P; Gaspari E; Donadio S
J Nat Prod; 2014 Jan; 77(1):79-84. PubMed ID: 24422756
[TBL] [Abstract][Full Text] [Related]
10. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
11. The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges.
van den Hooven HW; Lagerwerf FM; Heerma W; Haverkamp J; Piard JC; Hilbers CW; Siezen RJ; Kuipers OP; Rollema HS
FEBS Lett; 1996 Aug; 391(3):317-22. PubMed ID: 8764998
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of thioether-bridged bacteriocins.
Lohans CT; Vederas JC
J Antibiot (Tokyo); 2014 Jan; 67(1):23-30. PubMed ID: 24022605
[TBL] [Abstract][Full Text] [Related]
13. Structure and dynamics of the lantibiotic mutacin 1140.
Smith L; Zachariah C; Thirumoorthy R; Rocca J; Novák J; Hillman JD; Edison AS
Biochemistry; 2003 Sep; 42(35):10372-84. PubMed ID: 12950164
[TBL] [Abstract][Full Text] [Related]
14. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri.
Petersen J; Boysen A; Fogh L; Tabermann K; Kofoed T; King A; Schrotz-King P; Hansen MC
Biol Chem; 2009; 390(5-6):437-44. PubMed ID: 19361283
[TBL] [Abstract][Full Text] [Related]
16. NMR as an effective tool for the structure determination of lasso peptides.
Xie X; Marahiel MA
Chembiochem; 2012 Mar; 13(5):621-5. PubMed ID: 22278977
[No Abstract] [Full Text] [Related]
17. Purification, characterization, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis.
Holtsmark I; Mantzilas D; Eijsink VG; Brurberg MB
Appl Environ Microbiol; 2006 Sep; 72(9):5814-21. PubMed ID: 16957199
[TBL] [Abstract][Full Text] [Related]
18. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
Ekkelenkamp MB; Hanssen M; Danny Hsu ST; de Jong A; Milatovic D; Verhoef J; van Nuland NA
FEBS Lett; 2005 Mar; 579(9):1917-22. PubMed ID: 15792796
[TBL] [Abstract][Full Text] [Related]
19. Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.
Smith L; Novák J; Rocca J; McClung S; Hillman JD; Edison AS
Eur J Biochem; 2000 Dec; 267(23):6810-6. PubMed ID: 11082191
[TBL] [Abstract][Full Text] [Related]
20. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
